Department of Surgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Amherst, NY 14260-4200, USA.
Tissue Eng Part A. 2011 Mar;17(5-6):665-75. doi: 10.1089/ten.TEA.2010.0125. Epub 2010 Dec 18.
Despite significant advances in management of severe wounds such as burns and chronic ulcers, autologous split-thickness skin grafts are still the gold standard of care. The main problems with this approach include pain and discomfort associated with harvesting autologous tissue, limited availability of donor sites, and the need for multiple surgeries. Although tissue engineering has great potential to provide alternative approaches for tissue regeneration, several problems have hampered progress in translating technological advances to clinical reality. Specifically, engineering of skin substitutes requires long culture times and delayed vascularization after implantation compromises graft survival. To address these issues we developed a novel two-prong strategy for tissue regeneration in vivo: (1) vascularization of acellular dermal scaffolds by infiltration of angiogenic factors; and (2) generation of stratified epidermis by in situ delivery of epidermal keratinocytes onto the prevascularized dermal support. Using athymic mouse as a model system, we found that incorporation of angiogenic factors within acellular human dermis enhanced the density and diameter of infiltrating host blood vessels. Increased vascularization correlated with enhanced proliferation and stratification of the neoepidermis originating from the fibrin-keratinocyte cell suspension. This strategy promoted tissue regeneration in vivo with no need for engineering skin substitutes; therefore, it may be useful for treatment of major wounds when skin donor sites are scarce and rapid wound coverage is required.
尽管在严重创伤(如烧伤和慢性溃疡)的治疗方面取得了重大进展,但自体刃厚皮片仍然是治疗的金标准。这种方法的主要问题包括与采集自体组织相关的疼痛和不适、供体部位的有限可用性以及需要多次手术。尽管组织工程学具有为组织再生提供替代方法的巨大潜力,但仍有几个问题阻碍了技术进步转化为临床现实。具体来说,皮肤替代物的工程化需要长时间的培养,并且植入后的血管化延迟会影响移植物的存活。为了解决这些问题,我们开发了一种用于体内组织再生的新的双管齐下策略:(1)通过浸润血管生成因子使脱细胞真皮支架血管化;(2)通过将表皮角质形成细胞原位递送至预先血管化的真皮支架上来生成分层表皮。我们使用无胸腺小鼠作为模型系统,发现将血管生成因子掺入脱细胞人真皮中可增强宿主血管的密度和直径。增加的血管化与源自纤维蛋白-角质形成细胞细胞悬浮液的新生表皮的增殖和分层增强相关。这种策略无需工程化皮肤替代物即可促进体内组织再生;因此,当皮肤供体部位稀缺且需要快速覆盖伤口时,它可能对治疗大伤口有用。